Voloridge Investment Management
INBX

Voloridge Investment Management’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Voloridge Investment Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,710
Closed -$197K – 1564
2023
Q3 		$197K Buy
+10,710
New +$224K ﹤0.01% 1325
2023
Q2 		– Sell
-92,107
Closed -$1.74M – 1639
2023
Q1 		$1.74M Sell
92,107
-72,965
-44% -$1.7M 0.01% 1013
2022
Q4 		$4.07M Buy
+165,072
New +$4.85M 0.02% 722
2022
Q2 		– Sell
-31,466
Closed -$701K – 1712
2022
Q1 		$701K Buy
+31,466
New +$803K ﹤0.01% 1190

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Voloridge Investment Management's INBX Position: Q4 2023 in Review

Voloridge Investment Management sold out of Inhibrx, Inc. Common Stock (INBX) in Q4 2023, closing a stake of 10,710 shares — an estimated $197K sold.

Voloridge Investment Management first reported a position in INBX in Q1 2022 and held it in 4 quarters. The position peaked at $4.07M in Q4 2022. 127 funds tracked by Wall St. Rank hold INBX as of Q4 2023.

  • Voloridge Investment Management reported no remaining Inhibrx, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Voloridge Investment Management sold 10,710 Inhibrx, Inc. Common Stock shares in Q4 2023, an estimated $197K.
  • Voloridge Investment Management first reported a position in Inhibrx, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
  • Voloridge Investment Management's Inhibrx, Inc. Common Stock position peaked at $4.07M in Q4 2022.
  • 127 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q4 2023.

Based on Voloridge Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.